Realigning Patients & Scientists Through Decentralized Science (DeSci): A Primer on BIO
A primer on how BIO supercharges science — and how you can get in on the action.
“The biggest innovations of the 21st century will be at the intersection of biology and technology.” — Steve Jobs
Our mission at BIO is to leverage crypto technologies to accelerate the commercialization of cutting-edge scientific breakthroughs, ultimately expanding access to life-changing innovations for those who need them most.
Who’s that, exactly? For the purposes of this article, we’ll highlight:
- Medical patients who want a more efficient way to fund and obtain life-changing treatments and cures.
- Scientists who need better access to capital and talent to accelerate and commercialize their research.
Supercharging science
Inspired by Professor Andrew Lo’s Megafund concept, BIO protocol accelerates (and democratizes) scientific progress to help patients and scientists overcome some of the typical hurdles of biomedical R&D.
Due to the high-risk nature of early-stage science funding, too much medical innovation fails to attract sufficient capital and is left collecting dust on the shelves of academia. At the same time, the medical industry has increasingly followed a herd mentality in prioritizing low-risk innovation with marginal societal benefits.
BIO protocol helps online communities take science into their own hands. Using decentralized technologies and new economic and legal frameworks, BIO seeks to unite isolated islands of knowledge, data and capital in order to slash drug development cycles and costs, while creating shared IP ownership between patients and scientists worldwide.
For scientists, biotech founders and patients looking for more exposure to scientific innovation, the opportunities are vast: supercharging R&D productivity for researchers, unlocking radical new therapies, and providing affordable medicines and health products to patients globally.